Zhejiang Tianyu Pharmaceutical Co., Ltd.
SZSE:300702.SZ
20.8 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 759.324 | 698.599 | 666.806 | 569.891 | 682.895 | 662.311 | 518.57 | 569.175 | 777.214 | 582.284 | 610.46 | 724.036 | 749.898 | 605.175 | 572.702 | 608.21 | 758.923 | 583.272 | 672.126 | 763.207 | 568.792 | 527.766 | 604.618 | 479.774 | 498.438 | 463.302 | 357.104 | 347.634 | 298.917 | 305.309 | 273.961 | 322.427 | 286.587 | 266.396 | 240.29 | 313.444 |
| Cost of Revenue
| 475.432 | 472.285 | 429.756 | 393.369 | 445.896 | 419.106 | 307.038 | 335.038 | 476.039 | 545.809 | 470.008 | 561.158 | 498.63 | 408.814 | 374.893 | 387.184 | 441.309 | 346.129 | 278.212 | 353.596 | 273.071 | 204.284 | 251.359 | 212.82 | 256.283 | 234.239 | 197.573 | 245.54 | 198.916 | 208.232 | 164.683 | 186.983 | 179.173 | 167.458 | 147.099 | 193.36 |
| Gross Profit
| 283.892 | 226.314 | 237.049 | 176.521 | 237 | 243.205 | 211.532 | 234.137 | 301.175 | 36.475 | 140.452 | 162.878 | 251.267 | 196.361 | 197.809 | 221.026 | 317.614 | 237.143 | 393.914 | 409.61 | 295.72 | 323.482 | 353.259 | 266.953 | 242.155 | 229.063 | 159.531 | 102.094 | 100.001 | 97.077 | 109.278 | 135.444 | 107.414 | 98.938 | 93.191 | 120.084 |
| Gross Profit Ratio
| 0.374 | 0.324 | 0.355 | 0.31 | 0.347 | 0.367 | 0.408 | 0.411 | 0.388 | 0.063 | 0.23 | 0.225 | 0.335 | 0.324 | 0.345 | 0.363 | 0.419 | 0.407 | 0.586 | 0.537 | 0.52 | 0.613 | 0.584 | 0.556 | 0.486 | 0.494 | 0.447 | 0.294 | 0.335 | 0.318 | 0.399 | 0.42 | 0.375 | 0.371 | 0.388 | 0.383 |
| Reseach & Development Expenses
| 53.453 | 58.498 | 62.67 | 59.992 | 50.058 | 62.686 | 58.819 | 69.82 | 52.497 | 64.579 | 60.607 | 55.119 | 50.798 | 64.461 | 52.152 | 63.81 | 46.978 | 60.343 | 52.994 | 41.528 | 24.199 | 34.097 | 30.607 | 26.301 | 22.906 | 24.856 | 19.125 | 54.271 | 16.686 | 78.86 | 9.313 | 30.247 | 0 | 58.73 | 0 | 10.925 |
| General & Administrative Expenses
| 77.27 | -132.798 | 194.656 | -38.064 | 76.815 | -115.005 | 167.8 | -42.989 | 85.652 | 101.868 | 218.519 | -43.75 | 99.724 | -184.006 | 245.174 | -20.429 | 99.11 | -159.918 | 100.711 | -9.312 | 67.849 | -94.5 | 78.094 | -18.392 | 64.182 | -70.201 | 61.417 | -27.696 | 61.626 | -102.466 | 56.835 | -23.984 | 55.584 | -96.353 | 51.811 | 47.096 |
| Selling & Marketing Expenses
| 33.011 | -3.969 | 58.456 | 29.499 | 24.443 | 36.579 | 19.895 | 28.097 | 13.214 | 13.732 | 14.371 | 9.743 | 9.58 | 4.554 | 9.573 | 8.852 | 9.224 | -11.111 | 12.723 | 18.08 | 13.653 | 15.39 | 10.542 | 8.744 | 8.865 | 18.397 | 6.848 | 5.633 | 6.597 | 8.345 | 5.515 | 7.718 | 5.469 | 6.771 | 6.974 | 6.252 |
| SG&A
| 110.281 | -136.767 | 253.112 | 87.592 | 101.274 | -78.426 | 187.696 | -14.891 | 98.867 | 116.313 | 232.891 | -34.007 | 109.304 | -179.452 | 254.747 | -11.577 | 108.333 | -171.029 | 113.434 | 8.768 | 81.502 | -79.11 | 88.636 | -9.648 | 73.048 | -51.803 | 68.264 | -22.063 | 68.222 | -94.122 | 62.35 | -16.267 | 61.053 | -89.582 | 58.785 | 53.348 |
| Other Expenses
| 24.454 | 326.328 | -117.07 | -18.243 | -12.575 | 5.107 | -0.225 | -2.655 | -1.058 | 0 | -1.617 | -2.612 | -0.223 | -16.848 | -2.097 | -2.026 | -0.701 | 0.924 | -4.975 | 0.512 | -1.389 | 9.803 | -0.629 | 12.271 | -0.886 | -19.998 | -1.137 | -1.832 | -0.212 | -7.417 | 2.587 | 3.917 | -0.279 | 3.477 | 0.877 | 1.171 |
| Operating Expenses
| 188.188 | 248.06 | 198.713 | 165.827 | 163.907 | 219.895 | 138.27 | 161.94 | 153.614 | 198.794 | 168.504 | 138.414 | 157.521 | 180.172 | 175.945 | 184.189 | 156.818 | 153.117 | 169.18 | 154.298 | 103.258 | 158.868 | 121.629 | 107.552 | 90.579 | 118.142 | 90.289 | 83.477 | 69.904 | 73.439 | 66.349 | 74.304 | 62.305 | 74.97 | 61.106 | 55.856 |
| Operating Income
| 95.703 | -21.746 | 54.279 | 10.694 | 73.093 | -30.042 | -0.576 | -25.803 | 127.168 | -174.415 | -49.286 | 14.857 | 99.45 | -1.654 | 34.305 | 50.711 | 156.718 | 100.378 | 231.777 | 248.009 | 195.581 | 166.524 | 225.827 | 143.481 | 152.48 | 98.55 | 50.104 | 20.714 | 26.368 | -3.409 | 34.847 | 49.898 | 38.552 | 21.453 | 28.652 | 53.175 |
| Operating Income Ratio
| 0.126 | -0.031 | 0.081 | 0.019 | 0.107 | -0.045 | -0.001 | -0.045 | 0.164 | -0.3 | -0.081 | 0.021 | 0.133 | -0.003 | 0.06 | 0.083 | 0.207 | 0.172 | 0.345 | 0.325 | 0.344 | 0.316 | 0.374 | 0.299 | 0.306 | 0.213 | 0.14 | 0.06 | 0.088 | -0.011 | 0.127 | 0.155 | 0.135 | 0.081 | 0.119 | 0.17 |
| Total Other Income Expenses Net
| 0.226 | -6.342 | -15.495 | -2.018 | -13.163 | 20.76 | -0.225 | -2.655 | -1.058 | 3.343 | -21.347 | -2.612 | 7.511 | -16.848 | 6.229 | 14.429 | -0.622 | 50.322 | -4.975 | -1.429 | -0.385 | -2.196 | -0.629 | -4.623 | -0.886 | -3.27 | -20.275 | 3.157 | -3.941 | -6.551 | 0.188 | 3.12 | -6.836 | 1.067 | -2.839 | 1.067 |
| Income Before Tax
| 95.929 | -28.088 | 38.784 | 9.858 | 60.726 | -24.935 | -0.801 | -28.457 | 126.11 | -171.072 | -50.903 | 12.245 | 99.227 | -18.502 | 32.208 | 48.685 | 156.018 | 101.302 | 226.802 | 246.58 | 194.192 | 164.329 | 225.198 | 142.982 | 151.594 | 95.28 | 48.967 | 18.882 | 26.156 | -9.96 | 37.364 | 53.018 | 38.273 | 22.52 | 29.246 | 54.242 |
| Income Before Tax Ratio
| 0.126 | -0.04 | 0.058 | 0.017 | 0.089 | -0.038 | -0.002 | -0.05 | 0.162 | -0.294 | -0.083 | 0.017 | 0.132 | -0.031 | 0.056 | 0.08 | 0.206 | 0.174 | 0.337 | 0.323 | 0.341 | 0.311 | 0.372 | 0.298 | 0.304 | 0.206 | 0.137 | 0.054 | 0.088 | -0.033 | 0.136 | 0.164 | 0.134 | 0.085 | 0.122 | 0.173 |
| Income Tax Expense
| 9.746 | 1.091 | 6.221 | -4.021 | 19.413 | 16.502 | -1.484 | 3.668 | 25.872 | 13.435 | 5.281 | 2.017 | 14.505 | -17.135 | 6.785 | 1.525 | 22.557 | 12.164 | 30.165 | 31.786 | 27.7 | 22.936 | 35.173 | 17.078 | 23.43 | 10.48 | 10.681 | -1.328 | 5.804 | -4.03 | 6.618 | 8.801 | 7.125 | 1.085 | 2.75 | 9.45 |
| Net Income
| 86.183 | -29.179 | 31.899 | 12.698 | 40.517 | -41.436 | 0.683 | -32.126 | 100.238 | -157.638 | -56.184 | 10.228 | 84.721 | -1.368 | 25.423 | 47.16 | 133.461 | 89.138 | 196.637 | 214.794 | 166.492 | 141.393 | 190.025 | 125.904 | 128.164 | 84.8 | 38.287 | 20.21 | 20.352 | -5.93 | 30.747 | 44.217 | 31.148 | 21.435 | 26.496 | 44.792 |
| Net Income Ratio
| 0.114 | -0.042 | 0.048 | 0.022 | 0.059 | -0.063 | 0.001 | -0.056 | 0.129 | -0.271 | -0.092 | 0.014 | 0.113 | -0.002 | 0.044 | 0.078 | 0.176 | 0.153 | 0.293 | 0.281 | 0.293 | 0.268 | 0.314 | 0.262 | 0.257 | 0.183 | 0.107 | 0.058 | 0.068 | -0.019 | 0.112 | 0.137 | 0.109 | 0.08 | 0.11 | 0.143 |
| EPS
| 0.25 | -0.084 | 0.093 | 0.037 | 0.12 | -0.12 | 0.002 | -0.093 | 0.29 | -0.46 | -0.16 | 0.029 | 0.24 | -0.004 | 0.07 | 0.14 | 0.69 | 0.28 | 0.61 | 0.66 | 0.52 | 0.43 | 0.59 | 0.4 | 0.39 | 0.26 | 0.12 | 0.061 | 0.061 | -0.019 | 0.13 | 0.18 | 0.13 | 0.089 | 0.11 | 0.19 |
| EPS Diluted
| 0.25 | -0.084 | 0.093 | 0.037 | 0.12 | -0.12 | 0.002 | -0.093 | 0.29 | -0.46 | -0.16 | 0.029 | 0.24 | -0.004 | 0.07 | 0.14 | 0.68 | 0.28 | 0.6 | 0.66 | 0.51 | 0.43 | 0.58 | 0.39 | 0.38 | 0.26 | 0.12 | 0.061 | 0.061 | -0.019 | 0.13 | 0.18 | 0.13 | 0.089 | 0.11 | 0.19 |
| EBITDA
| 107.493 | -14.881 | 52.004 | 104.732 | 157.09 | 70.555 | 92.462 | 83.97 | 212.984 | -113.357 | 29.087 | 78.864 | 165.198 | 6.403 | 87.495 | 92.746 | 199.88 | 139.145 | 253.5 | 279.457 | 219.871 | 193.745 | 252.329 | 170.675 | 180.293 | 99.939 | 77.745 | 35.754 | 30.496 | 13.518 | 52.26 | 68.035 | 51.389 | 43.127 | 36.045 | 67.364 |
| EBITDA Ratio
| 0.142 | -0.021 | 0.078 | 0.184 | 0.23 | 0.107 | 0.178 | 0.148 | 0.274 | -0.195 | 0.048 | 0.109 | 0.22 | 0.011 | 0.153 | 0.152 | 0.263 | 0.239 | 0.377 | 0.366 | 0.387 | 0.367 | 0.417 | 0.356 | 0.362 | 0.216 | 0.218 | 0.103 | 0.102 | 0.044 | 0.191 | 0.211 | 0.179 | 0.162 | 0.15 | 0.215 |